MLC1 and infection: Two viremic and untreated HIV-infected subjects (#039 and #016) with comparable VL (46731 versus 41023 viral RNA copy/ml of plasma) were recruited during the primary phase of infection (day 92 and day 155 respectively) and followed longitudinally (Figure 1).